Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia
Open Access
- 1 January 2013
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 11 (1) , 189
Abstract
Chronic inflammation has been recognized to foster tumour development. Whether chemotherapy can be used to neutralize chronic inflammation is unclear.Keywords
This publication has 41 references indexed in Scilit:
- Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancerBritish Journal of Cancer, 2013
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based studyThe Lancet Oncology, 2013
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?Science, 2013
- Tumor-Associated Neutrophils: New Targets for Cancer TherapyCancer Research, 2011
- Is chemotherapy‐induced neutropenia a prognostic factor in patients with ovarian cancer?Acta Obstetricia et Gynecologica Scandinavica, 2010
- Role of Hematotoxicity and Sex in Patients With Hodgkin's Lymphoma: An Analysis From the German Hodgkin Study GroupJournal of Clinical Oncology, 2005
- Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trialsThe Lancet Oncology, 2005
- Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A European Organisation for Research and Treatment of Cancer–Italian Sarcoma Group–Australasian Gastrointestinal Trials Group StudyJournal of Clinical Oncology, 2005
- Hematologic counts and clinical correlates in 1201 newly diagnosed lung cancer patients.2004
- How to calculate the dose of chemotherapyBritish Journal of Cancer, 2002